Elisabet Mondragón
Biogipuzkoa Health Research Institute(ES)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological diseases and metabolism, RNA regulation and disease, Ginkgo biloba and Cashew Applications, Alzheimer's disease research and treatments
Most-Cited Works
- → Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry(2017)166 cited
- → The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight(2019)70 cited
- → The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies(2017)64 cited
- → Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach(2021)50 cited
- → DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease(2015)36 cited
- → Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia(2023)35 cited
- → Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls(2019)31 cited
- → The genetic architecture of Parkinson disease in Spain: characterizing population-specific risk, differential haplotype structures, and providing etiologic insight(2019)21 cited
- → Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2(2014)20 cited
- → Clinical Response to Thalidomide in the Treatment of Intracranial Tuberculomas(2013)9 cited